2015, Number 614
<< Back Next >>
Rev Med Cos Cen 2015; 72 (614)
Cistitis intersticial
Gil YM
Language: Spanish
References: 10
Page: 95-100
PDF size: 62.21 Kb.
ABSTRACT
Interstitial cystitis is a condition
characterized by urinary
symptoms (frequency, urgency,
nocturia, chronic bladder pain,
feeling of suprapubic pressure)
over 6 weeks duration in the
absence of infection or other
identifiable cause. Its etiology
is still unknown. It is more
common in women, and has
had an incidence of 2.7% -
6.5% of women in the United
States, equivalent to 3.3 to
7.9 million women. In men,
the incidence is much lower
with only 1.3% in the United
States. Diagnosis is by detailed
medical history, biopsies and
urodynamic studies; however
this is controversial because
earlier studies have described
this pathology as a diagnosis of
exclusion.
REFERENCES
Barr S. “Diagnosis and Management of Interstitial Cystitis”. Obstet Gynecol Clin N Am 41 .2014, p. 1-8.
Fall M, Logadottir Y, Peeker R. “Interstitial cystitis is bladder pain syndrome with Hunner’s lesion”. International Journal of Urology. Volume 21, Issue S1, 2014, p.1-8.
Kim J et al. “Antiproliferative Factor Signaling and Interstitial Cystitis/Painful Bladder Syndrome”. International Neurology Journal. 2011, volume 15, p. 184-191.
Liu B, Su Minzhi, Zhan Hailun, Yang F et al. “Adding a Sexual Dysfunction Domain to UPOINT System Improves Association With Symptoms in Women With Interstitial Cystitis and Bladder Pain Syndrome”. Female Urology, 0090- 4295/14, 2014, p. 1-5.
McLennan M. “Interstitial Cystitis Epidemiology, Pathophysiology, and Clinical Presentation”. Obstetrics Gynecology and Women’s Health, Saint Louis University School of Medicine. 2014, p. 1-11.
Peters KM, C. Jaeger, K. A. Killinger, B. Rosenberg and J. A. Boura. “Cystectomy for Ulcerative Interstitial Cystitis: Sequelae and Patients’ Perceptions of Improvement”. Urology and Andrology Department, Academic Hospital Caremau, Montpellier 2013; 63, p.753-758.
Rachel L. Fazio, Wunderlich T, Wilson N et al. “MMPI-2-RF characteristics of individuals with interstitial cystitis”. Journal of Psychosomatic Research. PSR- 08889, 2009, p. 1-4.
Sidhiki H et al. “Alterations of microbiota in urine from women with interstitial cystitis”. BMC Microbiology. 2012, 12:205, p. 1-11.
Sonal G, Abhishek S et al. “Role of inflammation in bladder function and interstitial cystitis”. Therapeutic Advances in Urology. 2011, volume 10, p. 1-15.
Woo HH, Chin PT, McNicholas TA et al: “Safety and feasibility of the prostatic urethral lift: a novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyper- plasia (BPH)”. BJU Int 2011; 108: 82.